Dual roles of lactylation modification in gastric cancer: Crosstalk between metabolic reprogramming and epigenetic regulation (Review)
Oncology Reports · 2026
DOI: 10.3892/or.2026.9138 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Reports, 2026. Verfasst von Yuanbo Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Acupuncture and Moxibustion, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui 230031, P.R. China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Epigenesis, Genetic, Protein Processing, Post-Translational, Histones. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Acupuncture and Moxibustion, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui 230031, P.R. China.
- Department of Endocrinology and Laboratory for Diabetes, The First Affiliated Hospital of University of Science and Technology of China, Hefei, Anhui 230001, P.R. China.
Zitieren
APA
Xu, Y., Wang, W., Zhang, Y., Fan, Y., Dong, W., & Yang, J. (2026). Dual roles of lactylation modification in gastric cancer: Crosstalk between metabolic reprogramming and epigenetic regulation (Review). Oncology Reports. https://doi.org/10.3892/or.2026.9138
Vancouver
Xu Y, Wang W, Zhang Y, Fan Y, Dong W, Yang J. Dual roles of lactylation modification in gastric cancer: Crosstalk between metabolic reprogramming and epigenetic regulation (Review). Oncology Reports. 2026. doi:10.3892/or.2026.9138
BibTeX
@article{Xu2026,
author = {Xu, Yuanbo and Wang, Weili and Zhang, Yating and Fan, Yinqiu and Dong, Wanying and Yang, Jun},
title = {Dual roles of lactylation modification in gastric cancer: Crosstalk between metabolic reprogramming and epigenetic regulation (Review)},
journal = {Oncology Reports},
year = {2026},
doi = {10.3892/or.2026.9138}
}
EUVIMED